<i>BCR-ABL1</i> transcripts (MR<sup>4.5</sup>) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia.

Korean J Intern Med · 2017 · PMC5214723 · PMID 27334764

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

showed a trendp = 0.089so close (0.05 < p ≤ 0.1)

We performed multivariate analyses including potential variables to evaluate the early predictive role of MR 4.5 at 3 months and found that MR 4.5 at 3 months was associated with a higher EFS ( p = 0.028) and showed a trend for a lower relapse rate ( p = 0.089).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.